138 related articles for article (PubMed ID: 11762709)
1. Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Asahi T; Shimabukuro M; Oshiro Y; Yoshida H; Takasu N
Thyroid; 2001 Nov; 11(11):1009-15. PubMed ID: 11762709
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling.
Hu LW; Benvenuti LA; Liberti EA; Carneiro-Ramos MS; Barreto-Chaves ML
Am J Physiol Regul Integr Comp Physiol; 2003 Dec; 285(6):R1473-80. PubMed ID: 12933361
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
Clozel JP; Kuhn H; Hefti F
J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
Yamamoto H; Avkiran M
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
7. Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Clozel JP; Hefti F
J Cardiovasc Pharmacol; 1988 May; 11(5):568-72. PubMed ID: 2455843
[TBL] [Abstract][Full Text] [Related]
8. Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.
Hu LW; Liberti EA; Barreto-Chaves ML
Virchows Arch; 2005 Mar; 446(3):265-9. PubMed ID: 15668802
[TBL] [Abstract][Full Text] [Related]
9. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
10. Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression.
Yoshiyama M; Takeuchi K; Hanatani A; Shimada T; Takemoto Y; Shimizu N; Omura T; Kim S; Iwao H; Yoshikawa J
Cardiovasc Drugs Ther; 1998 Mar; 12(1):57-70. PubMed ID: 9607133
[TBL] [Abstract][Full Text] [Related]
11. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.
Wambolt RB; Henning SL; English DR; Bondy GP; Allard MF
J Mol Cell Cardiol; 1997 Mar; 29(3):939-48. PubMed ID: 9152855
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
[TBL] [Abstract][Full Text] [Related]
13. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism.
Kobori H; Ichihara A; Suzuki H; Takenaka T; Miyashita Y; Hayashi M; Saruta T
Am J Physiol; 1997 Aug; 273(2 Pt 2):H593-9. PubMed ID: 9277473
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
Basset A; Blanc J; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
Tavares FM; da Silva IB; Gomes DA; Barreto-Chaves ML
Cardiovasc Drugs Ther; 2013 Oct; 27(5):393-402. PubMed ID: 23807455
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
[TBL] [Abstract][Full Text] [Related]
17. Reduced tolerance of global ischemia in the hypertrophied heart. Effect of coronary flow regulation during reperfusion on postischemic recovery.
Yamamoto H; Yamamoto F; Goh K; Sasajima T
Jpn J Thorac Cardiovasc Surg; 2001 May; 49(5):287-95. PubMed ID: 11431947
[TBL] [Abstract][Full Text] [Related]
18. Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts.
Pantos CI; Mourouzis IS; Tzeis SM; Malliopoulou V; Cokkinos DD; Asimacopoulos P; Carageorgiou HC; Varonos DD; Cokkinos DV
J Cardiovasc Pharmacol; 2000 Sep; 36(3):384-9. PubMed ID: 10975597
[TBL] [Abstract][Full Text] [Related]
19. Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats.
Clozel JP; Véniant M; Hess P; Sprecher U
Hypertension; 1991 Oct; 18(4 Suppl):II8-14. PubMed ID: 1833328
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition.
Hempel P; Hoch B; Bartel S; Karczewski P
Basic Res Cardiol; 2002; 97 Suppl 1():I96-101. PubMed ID: 12479242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
